Studying Long COVID-19 Symptoms in Canary Islands Patients
Observes physical and daily-function changes in adults recovering from COVID-19 at 12 weeks.
Plain-language title generated from the registry record
Registry title: Prevalence of Long COVID-19 in the Canary Islands
Key facts
- Where
- Las Palmas de Gran Canaria, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who tested positive for COVID-19 and still have symptoms at least 12 weeks later. It studies long COVID.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- Symptoms linked to COVID-19 that last at least 12 weeks after the infection was detected.
- Biomarker or test result
- A positive COVID-19 test since March 14, 2020.
Main reasons for not taking part
- Health problems before COVID-19 with symptoms like post-acute COVID-19
- Fibromyalgia
- Chronic fatigue
- Neuromuscular disease
- Treatment for active cancer
Read by machine on 12 November 2026.
Where in Spain
- University of Las Palmas de Gran CanariaLas Palmas de Gran Canaria, SpainContact: Anibal Báez, ProfessorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Las Palmas de Gran Canaria
- Trial code
- NCT05228691
- Record updated
- 28 August 2025
- Original description
With more than 246 million people diagnosed with coronavirus 2019 (COVID-19) around the world, many of whom have required medical attention for past 23 months, greater emphasis is being placed on post-acute care of COVID-19 survivors. According to recent data, millions of patients who have recovered from acute COVID-19 are experiencing persistent symptoms, which lead to disability and impaired activities of daily living.Read full original descriptionShow less
Long COVID: Evaluation of Physical and Functional Status
With more than 246 million people diagnosed with coronavirus 2019 (COVID-19) around the world, many of whom have required medical attention for past 23 months, greater emphasis is being placed on post-acute care of COVID-19 survivors. According to recent data, millions of patients who have recovered from acute COVID-19 are experiencing persistent symptoms, which lead to disability and impaired activities of daily living.
Various terms have been used to describe the condition of patients who do not return to their initial health status to include post-acute sequelae of COVID-19, such as post-acute COVID syndrome (PACS) and Long COVID.
The growing global burden of COVID-19 suggests that the potential effects of Long COVID in public health are vast even if Long COVID is experienced by a small proportion of patients recovering from acute infection.
The ability to identify patients at high risk for Long COVID and forecasting medical resource requirements is of important clinical utility in the present.
In view of the large number of people surviving after infection with COVID-19 and that should require follow-up, determine which patients are at risk of have Long COVID and who require close monitoring is crucial. In this study, therefore, we set out to analyze what type of patient profile with COVID-19 who, after 12 weeks of having suffered the infection, experiences the signs and symptoms described by current literature.
Inclusion: Have been positive for COVID-19 since the declaration of the state of alarm throughout the Spanish territory to deal with the health emergency situation caused by COVID-19 (March 14, 2020); Symptoms associated with COVID-19 at least after 12 weeks of its detection; Adequate cognitive and physical level to understand and perform the tests evaluation.
Exclusion: Present comorbidities prior to suffering from COVID-19 whose symptoms are resemble Post-acute COVID-19; Neuromuscular disease; Person undergoing treatment for active cancer; Fibromyalgia; Chronic fatigue; Not having signed the informed consent.